Document k9z9nZqxDKg80MZ3oL8wkg3XJ

From: Sent: To: Subject: Jenny Ivarsson den 27 oktober 2023 11:45 'Edward Strange' Sv: Bio-Rad PFAS restriction meeting request Dear Edward, Thank you for your request, At this moment we are reviewing all comments received in the consultation and considering whether a revision of the restriction proposal is needed based on the submitted information. We would like to emphasize that ECHA Committees, RAC and SEAC, are working with their assessment sector by sector and our work on the comments and the adjustment of the proposal will be arranged according to the work planning of the Committees. If we have any question when looking into the information submitted by Bio-Rad, we will be happy to contact you via ECHA since they are responsible for the process. If and when this will be the case, I cannot say at the moment. Best regards, On behalf of the Swedish Chemicals Agency, Jenny Ivarsson Jenny Ivarsson Strategisk radgivare Utveckling\Klassificerings- och begransningsforslag Kemikalieinspektionen Tel dir: +46 8 519 41 363 Tel vx: 08 519 41100 www.kemikalieinspektionen.se Fran: Edward Strange < @pentagroup.co> Skickat: den 26 oktober 2023 13:11 Till: Registrator <=@kemi.se> Kopia: Jenny Ivarsson < @kemi.se> Amne: Bio-Rad PFAS restriction meeting request Mona Blomdin Persson Head of Department -- Development of legislation and other policy instruments Swedish Chemicals Agency, Sweden Dear Ms Blomdin Persson, I am writing on behalf of Bio-Rad Laboratories to request a meeting to discuss the proposed restriction of per- and polyfluoroalkyl substances (PFAS) in Europe. Bio-Rad's concerns stem from the fact that their products and use-cases, particularly analytical laboratory devices serving the Life Sciences industry, due to their innovative nature, are not adequately represented by any industry body. In the letter, Simon May, Ph.D., EVP & President, Life Sciences Group, Bio-Rad, asks for a possible meeting between his team and your team to discuss the company's use of PFAS and possible solutions for a transition period. Bio-Rad's commitment to minimizing our reliance on PFAS chemicals is unwavering. Yet, the looming restriction, if enforced without considering a derogation for such products, threatens to disrupt the operations of all labs in Europe that rely on Bio-Rad systems. with kind regards, Edward Strange on behalf of Bio-Rad Edward Strange Managing Director, Brussels / Transport and Mobility, Strategy M: +32 (0)479 46 57 93 T: +32 (0)2 234 6860 @pentagroup.co Rue de la Science 41, 1040 Brussels, Belgium EU Transparency Register ID Number: 3843982938-44 This e-mail and any accompanying attachments may contain confidential information meant only for the intended recipient. If you are not the intended recipient or have otherwise received this e-mail in error, please promptly notify the sender by return email and delete all copies of this transmission.